Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/5066
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorPRADO, Danilo M. L.
dc.contributor.authorBENATTI, Fabiana B.
dc.contributor.authorSA-PINTO, Ana L. de
dc.contributor.authorHAYASHI, Ana P.
dc.contributor.authorGUALANO, Bruno
dc.contributor.authorPEREIRA, Rosa M. R.
dc.contributor.authorSALLUM, Adriana M. E.
dc.contributor.authorBONFA, Eloisa
dc.contributor.authorSILVA, Clovis A.
dc.contributor.authorROSCHEL, Hamilton
dc.date.accessioned2014-04-25T21:50:16Z
dc.date.available2014-04-25T21:50:16Z
dc.date.issued2013
dc.identifier.citationARTHRITIS RESEARCH & THERAPY, v.15, n.2, article ID R46, 11p, 2013
dc.identifier.issn1478-6354
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/5066
dc.description.abstractIntroduction: Exercise training has emerged as a promising therapeutic strategy to counteract physical dysfunction in adult systemic lupus erythematosus. However, no longitudinal studies have evaluated the effects of an exercise training program in childhood-onset systemic lupus erythematosus (C-SLE) patients. The objective was to evaluate the safety and the efficacy of a supervised aerobic training program in improving the cardiorespiratory capacity in C-SLE patients. Methods: Nineteen physically inactive C-SLE patients were randomly assigned into two groups: trained (TR, n = 10, supervised moderate-intensity aerobic exercise program) and non-trained (NT, n = 9). Gender-,body mass index (BMI)- and age-matched healthy children were recruited as controls (C, n = 10) for baseline (PRE) measurements only. C-SLE patients were assessed at PRE and after 12 weeks of training (POST). Main measurements included exercise tolerance and cardiorespiratory measurements in response to a maximal exercise (that is, peak VO2, chronotropic reserve (CR), and the heart rate recovery (Delta HRR) (that is, the difference between HR at peak exercise and at both the first (Delta HRR1) and second (Delta HRR2) minutes of recovery after exercise). Results: The C-SLE NT patients did not present changes in any of the cardiorespiratory parameters at POST (P > 0.05). In contrast, the exercise training program was effective in promoting significant increases in time-to-exhaustion (P = 0.01; ES = 1.07), peak speed (P = 0.01; ES = 1.08), peak VO2 (P = 0.04; ES = 0.86), CR (P = 0.06; ES = 0.83), and in Delta HRR1 and Delta HRR2 (P = 0.003; ES = 1.29 and P = 0.0008; ES = 1.36, respectively) in the C-SLE TR when compared with the NT group. Moreover, cardiorespiratory parameters were comparable between C-SLE TR patients and C subjects after the exercise training intervention, as evidenced by the ANOVA analysis (P > 0.05, TR vs. C). SLEDAI-2K scores remained stable throughout the study. Conclusion: A 3-month aerobic exercise training was safe and capable of ameliorating the cardiorespiratory capacity and the autonomic function in C-SLE patients.
dc.description.sponsorshipFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/08302-0]
dc.description.sponsorshipConselho Nacional do Desenvolvimento Cientifico e Tecnologico [CNPQ - 300559/2009-7, 302724/2011-7]
dc.description.sponsorshipFederico Foundation
dc.description.sponsorshipNucleo de Apoio a Pesquisa Saude da Crianca e do Adolescente' da USP (NAP-CriAd)
dc.language.isoeng
dc.publisherBIOMED CENTRAL LTD
dc.relation.ispartofArthritis Research & Therapy
dc.rightsopenAccess
dc.subject.otherheart-rate recovery
dc.subject.otherdisease-activity
dc.subject.otheradult-onset
dc.subject.otherchronotropic incompetence
dc.subject.otherjuvenile dermatomyositis
dc.subject.otherrheumatic-disease
dc.subject.otheraerobic exercise
dc.subject.otherrisk-factors
dc.subject.otherchildren
dc.subject.otherfatigue
dc.titleExercise training in childhood-onset systemic lupus erythematosus: a controlled randomized trial
dc.typearticle
dc.rights.holderCopyright BIOMED CENTRAL LTD
dc.identifier.doi10.1186/ar4205
dc.identifier.pmid23531226
dc.subject.wosRheumatology
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
hcfmusp.author.externalROSCHEL, Hamilton:Univ Sao Paulo, Sch Med, Div Rheumatol, BR-05403000 Sao Paulo, Brazil; Univ Sao Paulo, Sch Phys Educ & Sport, BR-05025010 Sao Paulo, Brazil
hcfmusp.description.articlenumberR46
hcfmusp.description.issue2
hcfmusp.description.volume15
hcfmusp.origemWOS
hcfmusp.origem.idWOS:000331726600010
hcfmusp.origem.id2-s2.0-84875362918
hcfmusp.publisher.cityLONDON
hcfmusp.publisher.countryENGLAND
hcfmusp.relation.referenceAraujo DB, 2012, LUPUS, V21, P872, DOI 10.1177/0961203312441047
hcfmusp.relation.referenceArdoin SP, 2012, NAT REV RHEUMATOL, V8, P444, DOI 10.1038/nrrheum.2012.109
hcfmusp.relation.referenceAydemir M, 2010, LUPUS, V19, P255, DOI 10.1177/0961203309351540
hcfmusp.relation.referenceBaim S, 2005, J CLIN DENSITOM, V8, P371, DOI 10.1385/JCD:8:4:371
hcfmusp.relation.referenceBar-Or O, 2004, PEDIAT EXERCISE MED
hcfmusp.relation.referenceBenseler SM, 2007, RHEUM DIS CLIN N AM, V33, P471, DOI 10.1016/j.rdc.2007.07.008
hcfmusp.relation.referenceBraga A, 2005, CARDIOLOGIA EXERCICI, P128
hcfmusp.relation.referenceBrunner HI, 2002, ARTHRITIS RHEUM, V46, P436, DOI 10.1002/art.10072
hcfmusp.relation.referenceCarreno L, 1999, LUPUS, V8, P287, DOI 10.1191/096120399678847786
hcfmusp.relation.referenceCarvalho Maria Rosenilda P de, 2005, Arthritis Rheum, V53, P838, DOI 10.1002/art.21605
hcfmusp.relation.referenceChung CP, 2007, ANN RHEUM DIS, V66, P208, DOI 10.1136/ard.2006.054973
hcfmusp.relation.referenceClarke-Jenssen AC, 2005, ARTHRIT RHEUM-ARTHR, V53, P308, DOI 10.1002/art.21082
hcfmusp.relation.referenceCohen J, 1988, STAT POWER ANAL BEHA, P2
hcfmusp.relation.referenceCole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804
hcfmusp.relation.referenceCrabtree NJ, 2007, CURR CLIN PRACT, P41, DOI 10.1007/978-1-59745-211-3_3
hcfmusp.relation.referenceDaltroy LH, 1995, BRIT J RHEUMATOL, V34, P1064
hcfmusp.relation.referenceDogdu O, 2010, J RHEUMATOL, V37, P2511, DOI 10.3899/jrheum.100163
hcfmusp.relation.referencedo Prado DML, 2011, LUPUS, V20, P717, DOI 10.1177/0961203310397081
hcfmusp.relation.referenceEl Magadmi M, 2006, J RHEUMATOL, V33, P50
hcfmusp.relation.referenceGladman DD, 2002, J RHEUMATOL, V29, P288
hcfmusp.relation.referenceGonzalez B, 2005, LUPUS, V14, P918, DOI 10.1191/0961203303lu2183xx
hcfmusp.relation.referenceGualano B, 2010, AUTOIMMUN REV, V9, P569, DOI 10.1016/j.autrev.2010.04.001
hcfmusp.relation.referenceHochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928
hcfmusp.relation.referenceHoffman IEA, 2009, ANN RHEUM DIS, V68, P412, DOI 10.1136/ard.2008.094813
hcfmusp.relation.referenceHoughton KM, 2008, ARTHRIT RHEUM-ARTHR, V59, P537, DOI 10.1002/art.23534
hcfmusp.relation.referenceKamphuis S, 2010, NAT REV RHEUMATOL, V6, P538, DOI 10.1038/nrrheum.2010.121
hcfmusp.relation.referenceKeteyian SJ, 1999, AM HEART J, V138, P233, DOI 10.1016/S0002-8703(99)70106-7
hcfmusp.relation.referenceKodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681
hcfmusp.relation.referenceLevy DM, 2012, PEDIATR CLIN N AM, V59, P345, DOI 10.1016/j.pcl.2012.03.007
hcfmusp.relation.referenceMachado FA, 2011, ARQ BRAS CARDIOL, V97, P136
hcfmusp.relation.referenceMiossi R, 2012, ARTHRIT CARE RES, V64, P1159, DOI 10.1002/acr.21678
hcfmusp.relation.referenceNishime EO, 2000, JAMA-J AM MED ASSOC, V284, P1392, DOI 10.1001/jama.284.11.1392
hcfmusp.relation.referenceOmori C, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-270
hcfmusp.relation.referenceOmori CH, 2012, ARTHRIT CARE RES, V64, P1186, DOI 10.1002/acr.21684
hcfmusp.relation.referencePrado DM, 2011, MED SCI SPORT EXER, V43, P2221, DOI 10.1249/MSS.0b013e318223b177
hcfmusp.relation.referenceRamsey-Goldman R, 2000, ARTHRIT CARE RES, V13, P262, DOI 10.1002/1529-0131(200010)13:5<262::AID-ANR4>3.0.CO;2-8
hcfmusp.relation.referenceROBBNICHOLSON LC, 1989, BRIT J RHEUMATOL, V28, P500
hcfmusp.relation.referenceRosenwinkel Eric T., 2001, Cardiology Clinics, V19, P369, DOI 10.1016/S0733-8651(05)70223-X
hcfmusp.relation.referenceROWLAND TW, 1993, PEDIATRIC LABORATORY EXERCISE TESTING, P19
hcfmusp.relation.referenceStephens S, 2008, ARTHRIT RHEUM-ARTHR, V59, P1399, DOI 10.1002/art.24115
hcfmusp.relation.referenceTaylor A, 1997, J BONE MINER RES, V12, P652, DOI 10.1359/jbmr.1997.12.4.652
hcfmusp.relation.referenceTench C, 2002, J RHEUMATOL, V29, P474
hcfmusp.relation.referenceTench CM, 2003, RHEUMATOLOGY, V42, P1050, DOI 10.1093/rheumatology/keg289
dc.description.indexMEDLINE
dc.identifier.eissn1478-6362
hcfmusp.remissive.sponsorshipCNPq
hcfmusp.remissive.sponsorshipFAPESP
hcfmusp.remissive.sponsorshipFederico Foundation
hcfmusp.remissive.sponsorshipUSP
hcfmusp.remissive.sponsorshipCNPq
hcfmusp.remissive.sponsorshipFAPESP
hcfmusp.remissive.sponsorshipFederico Foundation
hcfmusp.remissive.sponsorshipUSP
hcfmusp.citation.scopus38
hcfmusp.scopus.lastupdate2022-06-24-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MCM
Departamento de Clínica Médica - FM/MCM

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - HC/ICr
Instituto da Criança - HC/ICr

Artigos e Materiais de Revistas Científicas - LIM/17
LIM/17 - Laboratório de Investigação em Reumatologia

Artigos e Materiais de Revistas Científicas - LIM/36
LIM/36 - Laboratório de Pediatria Clínica


Files in This Item:
File Description SizeFormat 
art_PRADO_Exercise_training_in_childhood_onset_systemic_lupus_erythematosus_2013.PDFpublishedVersion (English)343.57 kBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.